Salivary microbial counts and buffer capacity in children with acute lymphoblastic leukemia

Li-Wei Ou-Yang1, Pei-Ching Chang, Aileen I Tsai

  • 1Department of Pediatric Dentistry, Chang Gung Memorial Hospital, Chang Gung University College of Medicine, Taoyuan, Taiwan (Republic of China).

Pediatric Dentistry
|June 19, 2010
PubMed

Insights

Children with acute lymphoblastic leukemia (ALL) undergoing chemotherapy had lower salivary Streptococcus mutans but also reduced salivary buffer capacity. Oral prevention strategies are crucial for these patients, especially those with diminished buffer capacity.

Area of Science:

  • Pediatric Oncology
  • Oral Health
  • Immunocompromised Patients

Background:

  • Children undergoing chemotherapy for acute lymphoblastic leukemia (ALL) face unique oral health challenges.
  • Maintaining oral health is critical during cancer treatment to prevent complications.

Purpose of the Study:

  • To assess caries activity in children with ALL during maintenance chemotherapy.
  • To compare oral health parameters between ALL patients and healthy controls.

Main Methods:

  • Examined 46 children with ALL (age 3-12) undergoing maintenance chemotherapy.
  • Clinical dental examination (DMF/DEFTS) and salivary analysis (Streptococcus mutans, lactobacilli, buffer capacity) were performed.
  • A control group of age and sex-matched healthy children was included for comparison.

Main Results:

  • Salivary Streptococcus mutans counts were significantly lower in ALL children (P<.001).
  • Salivary lactobacilli counts were similar between groups (P=.47).
  • ALL children exhibited significantly lower salivary buffer capacity (P=.002) and a trend towards higher caries scores (DEFTS/DMFTS).

Conclusions:

  • Children with ALL undergoing chemotherapy present with altered salivary parameters, notably reduced buffer capacity.
  • Targeted oral prevention strategies are recommended for ALL patients, particularly those with low salivary buffer capacity.
Abstract